30
三月
2021
6th Oligonucleotide & Precision Therapeutics
OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process. Join us in March when we bring together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers. Optimize your drug design, delivery and performance, accelerate time to market and achieve commercial success.